首页> 外文会议>Global Congress on Manufacturing and Management >Clinical Study on Computerized Molecular Imaging Tracing Stem Cell Transplantation for Patients with Myocardial Infarction
【24h】

Clinical Study on Computerized Molecular Imaging Tracing Stem Cell Transplantation for Patients with Myocardial Infarction

机译:心肌梗死患者计算机化分子成像跟踪干细胞移植的临床研究

获取原文

摘要

To explore the clinical application value of computer molecular imaging tracing stem cell transplantation in the treatment of myocardial infarction. Method: 90 patients with myocardial infarction admitted in our hospital from 2014.06 to 2016.06 were selected as subjects of this study, were randomly divided into two groups of 45 cases, the control group was treated with conventional therapy. The observation group was given molecular imaging tracing stem cell transplantation on the basis of conventional therapy. The patients in the two groups were treated for 3 weeks consecutively. After treatment, the patients in the two groups were followed up for 6 months. The total effective rate, left ventricular function index and complication rate after treatment were observed and compared. Results: The total effective rate of the treatment group was 97.8%, which was significantly higher than that of the control group (75.6%). The difference was statistically significant (P <0.05). After different treatment, the levels of CO and LVEF in the observation group were significantly higher than those in the control group, and the LVESV was significantly lower than that in the control group (P <0.05). There was no significant difference in LVEDD between the two groups (P>0.05). The incidence of complications in the observation group was 4.4%, which was significantly lower than that in the control group (P <0.05). Conclusions: Molecular imaging tracer stem cell transplantation for the treatment of patients with MI, the effect is significant, can significantly improve ventricular systolic and diastolic function in patients, inhibit ventricular remodeling, and the incidence of complications during treatment is low, safe and reliable, help to improve the lives of MI patients Quality, improve the prognosis.
机译:探讨计算机分子成像跟踪干细胞移植治疗心肌梗死的临床应用价值。方法:从2014.06至2016年从2016年到2016年录取的90例心肌梗死患者被选为本研究的主题,随机分为两组45例,对照组进行常规治疗治疗。在常规治疗的基础上给出了观察组的分子成像跟踪干细胞移植。两组患者连续3周治疗。治疗后,两组患者随访6个月。观察并比较治疗后的总有效率,左心室功能指数和并发症率。结果:治疗组的总有效率为97.8%,显着高于对照组(75.6%)。差异有统计学意义(P <0.05)。在不同的治疗后,观察组中的CO和LVEF水平明显高于对照组中的水平,叶丝显着​​低于对照组(P <0.05)。两组之间的LVEDD没有显着差异(P> 0.05)。观察组并发症的发病率为4.4%,显着低于对照组(P <0.05)。结论:分子成像跟踪器干细胞移植治疗MI患者,效果显着,可以显着改善患者的心室收缩和舒张功能,抑制心室重塑,治疗过程中并发症的发生率低,安全可靠,帮助改善MI患者质量的生命,提高预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号